VNDRIQ — Vendor Comparison
Promaton vs Relu
Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.
Promaton
Dental AI Infrastructure
Verification pending
Relu
Dental AI Infrastructure
Last verified: October 1, 2026
VNDRIQ Scores
41
Overall
59
Overall
Approval Tier
BAA Status
PHI Exposure Risk
AI Training Risk
HIPAA Risk Level
Review Frequency
Quarterly
Quarterly
Recommended Use
Automated 3D segmentation of CBCT scans and treatment planning workflows for dental implantology and orthodontics.
Automated anatomical segmentation of CBCT scans, 3D scan fusion, and AI-driven design for dental labs and clinics.
Restrictions
Lacks publicly verifiable evidence of FDA marketing authorization for clinical diagnostic use in the United States; primarily operates under international quality standards.
Must be used by qualified healthcare professionals as an aid to diagnosis and treatment planning; not for autonomous clinical decision-making.
Executive Summary
Promaton
Dental AI Infrastructure
Promaton is classified as Restricted / Review Required with a BAA status of There is no publicly available evidence that Promaton offers a standard Business Associate Agreement (BAA) for U.S. healthcare providers.. PHI exposure is rated High and AI training risk is Medium. Automated 3D segmentation of CBCT scans and treatment planning workflows for dental implantology and orthodontics.
36
Privacy
37
Governance
35
Healthcare
55
AI Risk
Relu
Dental AI Infrastructure
Relu is classified as Conditional / Verify BAA with a BAA status of Not explicitly stated in public documentation; requires verification during contracting.. PHI exposure is rated Medium and AI training risk is Medium. Automated anatomical segmentation of CBCT scans, 3D scan fusion, and AI-driven design for dental labs and clinics.
61
Privacy
55
Governance
56
Healthcare
65
AI Risk
Recommended For
Promaton
Automated 3D segmentation of CBCT scans and treatment planning workflows for dental implantology and orthodontics.
Currently under review — not recommended for active PHI deployment
Relu
Automated anatomical segmentation of CBCT scans, 3D scan fusion, and AI-driven design for dental labs and clinics.
Organizations able to execute BAA prior to deployment
IT teams with capacity to verify data handling agreements
Governance Considerations
Promaton
PHI exposure is elevated. Review data flow documentation.
Quarterly reviews are required — establish internal review cadence.
Restrictions noted: Lacks publicly verifiable evidence of FDA marketing authorization for clinical diagnostic use in the United States; primarily operates under international quality standards.
Relu
Quarterly reviews are required — establish internal review cadence.
Restrictions noted: Must be used by qualified healthcare professionals as an aid to diagnosis and treatment planning; not for autonomous clinical decision-making.
Questions to Ask Before Approval
Has the vendor executed a Business Associate Agreement (BAA) with your organization?
Does the vendor use customer data to train AI models? Can you opt out?
Where is PHI stored, processed, and transmitted?
What data retention and deletion policies apply to your PHI?
Has the vendor undergone a third-party HIPAA or SOC 2 audit?
What is the vendor's incident response and breach notification process?
Does the vendor offer audit logging for PHI access?
What subprocessors have access to PHI through this vendor?
Request Vendor Evaluation
Get a structured risk assessment for any vendor.
Request Benchmark Report
Compare vendors across your full stack.
Book Governance Assessment
Talk to a VNDRIQ governance specialist.